Clinical Trial Update: Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

View source ↗

Summary

This clinical trial update examines the early and long-term efficacy and immune changes of dupilumab in prurigo nodularis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: UMC Utrecht | Conditions: Prurigo Nodularis (PN) | Status: RECRUITING